Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14279/30000
DC FieldValueLanguage
dc.contributor.authorKolte, Ashutosh-
dc.contributor.authorFesta, Giuseppe-
dc.contributor.authorRossi, Matteo-
dc.contributor.authorThrassou, Alkis-
dc.contributor.authorVrontis, Demetris-
dc.contributor.authorChristofi, Michael-
dc.date.accessioned2023-07-27T08:35:05Z-
dc.date.available2023-07-27T08:35:05Z-
dc.date.issued2022-09-01-
dc.identifier.citationThunderbird International Business Review, 2022, vol. 64, iss. 5, pp. 465 - 476en_US
dc.identifier.issn10964762-
dc.identifier.urihttps://hdl.handle.net/20.500.14279/30000-
dc.description.abstractThis study investigates the influence that business ambidexterity of the Indian pharmaceutical industry can exert on exports, after the evolution from producer—often with the support of foreign direct investments (FDIs)—to researcher. The growth rate of the sector has changed pace with the introduction of new rules regarding patents, impelling pharma enterprises to invest in research and development (R&D), also for the peculiar category of AYUSH. However, many aspects of this industrial evolution are, if anything, under researched. To fill this gap in knowledge, this research adopts a quantitative methodology on secondary data to investigate the effects and potentialities of ambidexterity, providing evidence from descriptive and inferential statistics. Insisting on traditional production of generics (exploitation) and investing in R&D (exploration) have been coherent with the rise in exports, but several factors still impede the development of the commercial potential of the Indian pharmaceutical industry, mostly due to low per capita health care spending, absence of reliable infrastructure, and severe market competition.en_US
dc.language.isoenen_US
dc.rights© The Authors. Thunderbird International Business Review published by Wiley Periodicals LLC.en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectambidexterityen_US
dc.subjectAYUSHen_US
dc.subjectIndiaen_US
dc.subjectpharmaceutical industryen_US
dc.subjectR&Den_US
dc.titleAmbidexterity's influence on export strategy development—The case of the Indian pharmaceutical industryen_US
dc.typeArticleen_US
dc.collaborationSavitribai Phule Pune Universityen_US
dc.collaborationUniversity of Salernoen_US
dc.collaborationUniversity of Sannioen_US
dc.collaborationUniversity of Nicosiaen_US
dc.collaborationCyprus University of Technologyen_US
dc.subject.categoryEconomics and Businessen_US
dc.journalsSubscriptionen_US
dc.countryIndiaen_US
dc.countryItalyen_US
dc.countryCyprusen_US
dc.subject.fieldSocial Sciencesen_US
dc.publicationPeer Revieweden_US
dc.identifier.doi10.1002/tie.22278en_US
dc.identifier.scopus2-s2.0-85132627155-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85132627155-
dc.relation.issue5en_US
dc.relation.volume64en_US
cut.common.academicyearemptyen_US
dc.identifier.spage465en_US
dc.identifier.epage476en_US
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_6501-
item.cerifentitytypePublications-
item.openairetypearticle-
crisitem.author.deptDepartment of Management, Entrepreneurship and Digital Business-
crisitem.author.facultyFaculty of Tourism Management, Hospitality and Entrepreneurship-
crisitem.author.orcid0000-0002-7457-2701-
crisitem.author.parentorgFaculty of Tourism Management, Hospitality and Entrepreneurship-
Appears in Collections:Άρθρα/Articles
CORE Recommender
Show simple item record

SCOPUSTM   
Citations 50

1
checked on Mar 14, 2024

Page view(s) 50

221
Last Week
5
Last month
34
checked on Mar 14, 2025

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons